Literature DB >> 30090486

Circulating miRNAs and their target genes associated with arsenism caused by coal-burning.

Baofei Sun1, Junchao Xue2, Jun Li1, Fei Luo2, Xiong Chen1, Yonglian Liu1, Qingling Wang1, Caihua Qi1, Zhonglan Zou1, Aihua Zhang1, Qizhan Liu2.   

Abstract

Endemic arsenism, caused by burning coal containing high levels of arsenic, is found only in the Guizhou and Shanxi Provinces of China. Dysregulated microRNAs (miRNAs), detected in the blood, are emerging as promising biomarkers. At present, little is known about the change and clinical efficacy of circulating miRNAs in patients with endemic arsenism produced by burning of coal. Here, we determined, by using TaqMan Human miRNA Array Chips, the differential expression of plasma miRNAs between patients with arsenism caused by coal-burning and a control group. Four increased miRNAs (miR-21, miR-145, miR-155, and miR-191) were verified in a larger sample by quantitative real-time PCR. Furthermore, bioinformatics and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses were used to associate changes in plasma levels of the miRNAs with their functions and their effects on various pathways. The results of chip array assays show that the levels of miR-21, miR-141, miR-148a, miR-145, miR-155, miR-191, miR-218, and miR-491 were most prominently increased and that the levels of miR-200b, miR-200c, miR-26, and miR-34c were decreased. The qRT-PCR results confirm that the circulating levels of miR-21, miR-145, miR-155, and miR-191 are increased in patients with arsenism caused by coal-burning. KEGG analyses show that these miRNAs inhibit the target genes of pathways related to immune inflammation, oxidative stress, and DNA damage repair. Therefore, the four miRNAs may be biomarkers of endemic arsenism caused by coal-burning. Further studies with larger samples should be performed to confirm these findings and to elucidate the underlying mechanisms.

Entities:  

Year:  2017        PMID: 30090486      PMCID: PMC6062399          DOI: 10.1039/c6tx00428h

Source DB:  PubMed          Journal:  Toxicol Res (Camb)        ISSN: 2045-452X            Impact factor:   3.524


  54 in total

1.  Quantification of circulating miRNAs in plasma: effect of preanalytical and analytical parameters on their isolation and stability.

Authors:  Ioanna S Sourvinou; Athina Markou; Evi S Lianidou
Journal:  J Mol Diagn       Date:  2013-08-27       Impact factor: 5.568

2.  Circulating microRNA as a biomarker for recovery in pediatric dilated cardiomyopathy.

Authors:  Shelley D Miyamoto; Anis Karimpour-Fard; Valencia Peterson; Scott R Auerbach; Kurt R Stenmark; Brian L Stauffer; Carmen C Sucharov
Journal:  J Heart Lung Transplant       Date:  2015-01-30       Impact factor: 10.247

Review 3.  Circulating microRNAs as diagnostic and prognostic tools for hepatocellular carcinoma.

Authors:  Yu-Cheng Zhang; Zhuo Xu; Tian-Fu Zhang; Ya-Li Wang
Journal:  World J Gastroenterol       Date:  2015-09-14       Impact factor: 5.742

4.  Age-related differences in the expression of circulating microRNAs: miR-21 as a new circulating marker of inflammaging.

Authors:  Fabiola Olivieri; Liana Spazzafumo; Gabriele Santini; Raffaella Lazzarini; Maria Cristina Albertini; Maria Rita Rippo; Roberta Galeazzi; Angela Marie Abbatecola; Fiorella Marcheselli; Daniela Monti; Rita Ostan; Elisa Cevenini; Roberto Antonicelli; Claudio Franceschi; Antonio Domenico Procopio
Journal:  Mech Ageing Dev       Date:  2012-10-02       Impact factor: 5.432

Review 5.  MicroRNAs potential utility in colon cancer: Early detection, prognosis, and chemosensitivity.

Authors:  Michael Hollis; Kavitha Nair; Arpita Vyas; Lakshmi Shankar Chaturvedi; Sahil Gambhir; Dinesh Vyas
Journal:  World J Gastroenterol       Date:  2015-07-21       Impact factor: 5.742

Review 6.  Genotoxic and epigenetic mechanisms in arsenic carcinogenicity.

Authors:  Elisa Bustaffa; Andrea Stoccoro; Fabrizio Bianchi; Lucia Migliore
Journal:  Arch Toxicol       Date:  2014-04-02       Impact factor: 5.153

7.  Inhibition of STAT3 enhances the radiosensitizing effect of temozolomide in glioblastoma cells in vitro and in vivo.

Authors:  Tae Jin Han; Bong Jun Cho; Eun Jung Choi; Dan Hyo Kim; Sang Hyuk Song; Sun Ha Paek; In Ah Kim
Journal:  J Neurooncol       Date:  2016-08-10       Impact factor: 4.130

Review 8.  MicroRNAs and oncogenic transcriptional regulatory networks controlling metabolic reprogramming in cancers.

Authors:  Pannapa Pinweha; Khanti Rattanapornsompong; Varodom Charoensawan; Sarawut Jitrapakdee
Journal:  Comput Struct Biotechnol J       Date:  2016-06-04       Impact factor: 7.271

9.  Health effects of exposure to natural arsenic in groundwater and coal in China: an overview of occurrence.

Authors:  Guangqian Yu; Dianjun Sun; Yan Zheng
Journal:  Environ Health Perspect       Date:  2007-01-09       Impact factor: 9.031

10.  Health effects of chronic arsenic exposure.

Authors:  Young-Seoub Hong; Ki-Hoon Song; Jin-Yong Chung
Journal:  J Prev Med Public Health       Date:  2014-09-11
View more
  2 in total

1.  Overexpression of hsa-miR-186 induces chromosomal instability in arsenic-exposed human keratinocytes.

Authors:  Jiguo Wu; Ana P Ferragut Cardoso; Vanessa A R States; Laila Al-Eryani; Mark Doll; Sandra S Wise; Shesh N Rai; J Christopher States
Journal:  Toxicol Appl Pharmacol       Date:  2019-06-06       Impact factor: 4.219

Review 2.  Arsenic-induced changes in miRNA expression in cancer and other diseases.

Authors:  Ana P Ferragut Cardoso; Karen T Udoh; J Christopher States
Journal:  Toxicol Appl Pharmacol       Date:  2020-10-28       Impact factor: 4.219

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.